Annual EBIT
-$8.93 M
+$3.73 M+29.48%
December 31, 2021
Summary
- As of February 10, 2025, EYES annual earnings before interest & taxes is -$8.93 million, with the most recent change of +$3.73 million (+29.48%) on December 31, 2021.
- During the last 3 years, EYES annual EBIT has risen by +$25.69 million (+74.20%).
Performance
EYES EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$3.13 M
-$913.00 K-41.20%
June 30, 2022
Summary
- As of February 10, 2025, EYES quarterly earnings before interest & taxes is -$3.13 million, with the most recent change of -$913.00 thousand (-41.20%) on June 30, 2022.
- Over the past year, EYES quarterly EBIT has dropped by -$833.00 thousand (-36.28%).
Performance
EYES Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$9.14 M
-$833.00 K-10.03%
June 30, 2022
Summary
- As of February 10, 2025, EYES TTM earnings before interest & taxes is -$9.14 million, with the most recent change of -$833.00 thousand (-10.03%) on June 30, 2022.
- Over the past year, EYES TTM EBIT has dropped by -$1.12 million (-14.02%).
Performance
EYES TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
EYES EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.5% | -36.3% | -14.0% |
| 3 y3 years | +74.2% | +58.6% | +70.1% |
| 5 y5 years | +68.8% | +54.5% | +70.1% |
EYES EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +142.4% | at low | +10.0% | at low |
| 5 y | 5-year | at high | +242.5% | +145.6% | +157.8% | +14.4% | +236.8% |
| alltime | all time | at high | +287.6% | +145.6% | +300.1% | +84.9% | +282.4% |
Second Sight Medical Products EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$3.13 M(+41.2%) | -$9.14 M(+10.0%) |
| Mar 2022 | - | -$2.22 M(+71.6%) | -$8.31 M(-7.0%) |
| Dec 2021 | -$8.93 M(-29.5%) | -$1.29 M(-48.4%) | -$8.93 M(+0.2%) |
| Sep 2021 | - | -$2.50 M(+9.0%) | -$8.92 M(+11.2%) |
| Jun 2021 | - | -$2.30 M(-19.2%) | -$8.02 M(+0.4%) |
| Mar 2021 | - | -$2.84 M(+123.2%) | -$7.99 M(-36.9%) |
| Dec 2020 | -$12.67 M(-58.6%) | -$1.27 M(-20.5%) | -$12.67 M(-34.9%) |
| Sep 2020 | - | -$1.60 M(-29.4%) | -$19.46 M(-23.6%) |
| Jun 2020 | - | -$2.27 M(-69.9%) | -$25.48 M(-17.2%) |
| Mar 2020 | - | -$7.52 M(-6.7%) | -$30.78 M(+0.6%) |
| Dec 2019 | -$30.60 M(-11.6%) | -$8.07 M(+5.9%) | -$30.60 M(-0.8%) |
| Sep 2019 | - | -$7.62 M(+0.7%) | -$30.85 M(-2.9%) |
| Jun 2019 | - | -$7.57 M(+3.1%) | -$31.78 M(-1.3%) |
| Mar 2019 | - | -$7.34 M(-11.8%) | -$32.20 M(-7.0%) |
| Dec 2018 | -$34.63 M(+21.0%) | -$8.32 M(-2.6%) | -$34.63 M(+2.6%) |
| Sep 2018 | - | -$8.55 M(+7.0%) | -$33.74 M(+5.6%) |
| Jun 2018 | - | -$7.99 M(-18.2%) | -$31.94 M(+3.6%) |
| Mar 2018 | - | -$9.77 M(+31.4%) | -$30.82 M(+7.7%) |
| Dec 2017 | -$28.61 M | -$7.43 M(+10.1%) | -$28.61 M(-9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$6.75 M(-1.8%) | -$31.56 M(-5.3%) |
| Jun 2017 | - | -$6.87 M(-9.0%) | -$33.31 M(-4.7%) |
| Mar 2017 | - | -$7.55 M(-27.2%) | -$34.94 M(+5.2%) |
| Dec 2016 | -$33.21 M(+65.7%) | -$10.38 M(+22.2%) | -$33.21 M(+17.3%) |
| Sep 2016 | - | -$8.50 M(-0.1%) | -$28.30 M(+15.7%) |
| Jun 2016 | - | -$8.51 M(+46.1%) | -$24.47 M(+17.0%) |
| Mar 2016 | - | -$5.82 M(+6.3%) | -$20.91 M(+4.3%) |
| Dec 2015 | -$20.05 M(-28.8%) | -$5.48 M(+17.5%) | -$20.05 M(-26.0%) |
| Sep 2015 | - | -$4.66 M(-5.8%) | -$27.09 M(-3.5%) |
| Jun 2015 | - | -$4.95 M(-0.3%) | -$28.07 M(-2.1%) |
| Mar 2015 | - | -$4.96 M(-60.4%) | -$28.68 M(+1.8%) |
| Dec 2014 | -$28.17 M(+56.9%) | -$12.52 M(+121.7%) | -$28.17 M(+41.0%) |
| Sep 2014 | - | -$5.65 M(+1.8%) | -$19.98 M(+5.6%) |
| Jun 2014 | - | -$5.55 M(+24.6%) | -$18.91 M(+8.3%) |
| Mar 2014 | - | -$4.45 M(+2.9%) | -$17.47 M(-2.7%) |
| Dec 2013 | -$17.95 M(+12.1%) | -$4.33 M(-5.5%) | -$17.95 M(+31.8%) |
| Sep 2013 | - | -$4.58 M(+11.6%) | -$13.63 M(+50.6%) |
| Jun 2013 | - | -$4.11 M(-16.9%) | -$9.05 M(+83.1%) |
| Mar 2013 | - | -$4.94 M | -$4.94 M |
| Dec 2012 | -$16.01 M | - | - |
FAQ
- What is Second Sight Medical Products annual earnings before interest & taxes?
- What is the all time high annual EBIT for Second Sight Medical Products?
- What is Second Sight Medical Products annual EBIT year-on-year change?
- What is Second Sight Medical Products quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Second Sight Medical Products?
- What is Second Sight Medical Products quarterly EBIT year-on-year change?
- What is Second Sight Medical Products TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Second Sight Medical Products?
- What is Second Sight Medical Products TTM EBIT year-on-year change?
What is Second Sight Medical Products annual earnings before interest & taxes?
The current annual EBIT of EYES is -$8.93 M
What is the all time high annual EBIT for Second Sight Medical Products?
Second Sight Medical Products all-time high annual earnings before interest & taxes is -$8.93 M
What is Second Sight Medical Products annual EBIT year-on-year change?
Over the past year, EYES annual earnings before interest & taxes has changed by +$3.73 M (+29.48%)
What is Second Sight Medical Products quarterly earnings before interest & taxes?
The current quarterly EBIT of EYES is -$3.13 M
What is the all time high quarterly EBIT for Second Sight Medical Products?
Second Sight Medical Products all-time high quarterly earnings before interest & taxes is -$1.27 M
What is Second Sight Medical Products quarterly EBIT year-on-year change?
Over the past year, EYES quarterly earnings before interest & taxes has changed by -$833.00 K (-36.28%)
What is Second Sight Medical Products TTM earnings before interest & taxes?
The current TTM EBIT of EYES is -$9.14 M
What is the all time high TTM EBIT for Second Sight Medical Products?
Second Sight Medical Products all-time high TTM earnings before interest & taxes is -$4.94 M
What is Second Sight Medical Products TTM EBIT year-on-year change?
Over the past year, EYES TTM earnings before interest & taxes has changed by -$1.12 M (-14.02%)